Literature DB >> 16622089

Impact of age related macular degeneration on quality of life.

J B Hassell1, E L Lamoureux, J E Keeffe.   

Abstract

AIMS: To describe the impact of age related macular degeneration (AMD) on quality of life and explore the association with vision, health, and demographic variables.
METHODS: Adult participants diagnosed with AMD and with impaired vision (visual acuity <6/12) were assessed with the Impact of Vision Impairment (IVI) questionnaire. Participants rated the extent that vision restricted participation in activities affecting quality of life and completed the Short Form General Health Survey (SF-12) and a sociodemographic questionnaire.
RESULTS: The mean age of the 106 participants (66% female) was 83.6 years (range 64-98). One quarter had mild vision impairment, (VA<6/12-6/18) and 75% had moderate or severely impaired vision. Participants reported from at least "a little" concern on 23 of the 32 IVI items including reading, emotional health, mobility, and participation in relevant activities. Those with mild and moderate vision impairment were similarly affected but significantly different from those with severe vision loss (p<0.05). Distance vision was associated with IVI scores but not age, sex, or duration of vision loss.
CONCLUSION: AMD affects many quality of life related activities and not just those related to reading. Referral to low vision care services should be considered for people with mild vision loss and worse.

Entities:  

Mesh:

Year:  2006        PMID: 16622089      PMCID: PMC1857044          DOI: 10.1136/bjo.2005.086595

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Self-management of age-related macular degeneration and quality of life: a randomized controlled trial.

Authors:  Barbara L Brody; Anne-Catherine Roch-Levecq; Anthony C Gamst; Kellie Maclean; Robert M Kaplan; Stuart I Brown
Journal:  Arch Ophthalmol       Date:  2002-11

Review 2.  New treatments in age-related macular degeneration.

Authors:  Claire Y Hooper; Robyn H Guymer
Journal:  Clin Exp Ophthalmol       Date:  2003-10       Impact factor: 4.207

3.  Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.

Authors:  J D Stein; M M Brown; G C Brown; H Hollands; S Sharma
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Assessment of the impact of vision impairment.

Authors:  LeAnn M Weih; Jennifer B Hassell; Jill Keeffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

5.  Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation.

Authors:  S K West; B Munoz; G S Rubin; O D Schein; K Bandeen-Roche; S Zeger; S German; L P Fried
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

Review 6.  Quality of life of low-vision patients and outcomes of low-vision rehabilitation.

Authors:  J Stelmack
Journal:  Optom Vis Sci       Date:  2001-05       Impact factor: 1.973

7.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer.

Authors:  M R Stevenson; P M Hart; A-M Montgomery; D W McCulloch; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

9.  Effect of depression on vision function in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; William S Tasman
Journal:  Arch Ophthalmol       Date:  2002-08

10.  Low vision services for vision rehabilitation in the United Kingdom.

Authors:  L E Culham; B Ryan; A J Jackson; A R Hill; B Jones; C Miles; J A Young; C Bunce; A C Bird
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

View more
  54 in total

1.  Computer use among patients with age-related macular degeneration.

Authors:  Barbara L Brody; Linda C Field; Anne-Catherine Roch-Levecq; Colin Depp; Steven D Edland; Lilit Minasyan; Stuart I Brown
Journal:  Ophthalmic Epidemiol       Date:  2012-08       Impact factor: 1.648

2.  The social impact of visual impairment.

Authors:  Geraint P Williams; Vanita Pathak-Ray; Michael W Austin
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

3.  Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.

Authors:  Joshua D Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P Lee; David W Hutton
Journal:  Ophthalmology       Date:  2014-01-07       Impact factor: 12.079

Review 4.  Applications of augmented reality in ophthalmology [Invited].

Authors:  Güneş Aydındoğan; Koray Kavaklı; Afsun Şahin; Pablo Artal; Hakan Ürey
Journal:  Biomed Opt Express       Date:  2020-12-21       Impact factor: 3.732

5.  Digital reader vs print media: the role of digital technology in reading accuracy in age-related macular degeneration.

Authors:  K Gill; A Mao; A M Powell; T Sheidow
Journal:  Eye (Lond)       Date:  2013-03-15       Impact factor: 3.775

6.  Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration.

Authors:  M Vukicevic; J Heraghty; R Cummins; B Gopinath; P Mitchell
Journal:  Eye (Lond)       Date:  2015-11-27       Impact factor: 3.775

7.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

8.  Neovascular AMD: an overlooked risk factor for injurious falls.

Authors:  S M Szabo; P A Janssen; K Khan; S R Lord; M J Potter
Journal:  Osteoporos Int       Date:  2009-07-23       Impact factor: 4.507

9.  Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008.

Authors:  Xinzhi Zhang; Kai McKeever Bullard; Mary Frances Cotch; M Roy Wilson; Barry W Rovner; Gerald McGwin; Cynthia Owsley; Lawrence Barker; John E Crews; Jinan B Saaddine
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.